Drugs / Flaxseed oil
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT01391624 | Aug 2010 → Jan 2011 | — | Federal University of São Paulo | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02400320 Comparator | Mar → Jun 2016 | irritant dermatitis | GlaxoSmithKline | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Flaxseed oil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01391624 ↗ |
| Known as | Linseed Oil | “Topical spray containing Diclofenac 1.16%, Linseed Oil 3%, Menthol 5%, Methyl salicylate 10%.” NCT02400320 ↗ |
| Route | Topical | “Topical spray” NCT02400320 ↗ |